Analyst Rating
based on 12 analysts
72.73%
Buy
9.09%
Hold
18.18%
Sell
Based on 12 analysts offering long term price targets for Narayana Hrudayalaya Ltd. An average target of ₹1369.08
Source: S&P Global Market Intelligence
Narayana Hrudayalaya Ltd Share analysis
Narayana Hrudayalaya Ltd price forecast by 12 analysts
Upside of6.64%
High
₹1600
Target
₹1369.08
Low
₹1000
Narayana Hrudayalaya Ltd target price ₹1369.08, a slight upside of 6.64% compared to current price of ₹1273.85. According to 12 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Narayana Hrudayalaya Ltd revenue growth forecast
Expected growth rate Q1, FY2026:28.29%
Forecast
Actual
Including amortisation and stock based compensations
Narayana Hrudayalaya Ltd EPS growth forecast
EPS estimate Q1, FY2026:15.25%
Forecast
Actual
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹1,263.5₹1,294.3552 Week's Low
52 Week's High
₹979.95₹1,444.9
| Returns % | |
| 1 Month Return | + 8.12 % |
| 3 Month Return | + 3.74 % |
| 1 Year Return | + 16.79 % |
| Market Stats | |
| Previous Close | ₹1,283.85 |
| Open | ₹1,289.90 |
| Volume | 1.86L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹26,236.86Cr |
Key Statistics
| P/E Ratio | 32.31 |
| PEG Ratio | 5.16 |
| Market Cap | ₹26,236.86 Cr |
| P/B Ratio | 14.21 |
| EPS | 38.64 |
| Dividend Yield | 0.31 |
| Sector | Healthcare |
| ROE | 25.66 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹26,236.86 Cr | 88.23% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹22,489.81 Cr | 36.38% | 0.58 | ₹336 Cr | ₹2,498 Cr | |
| BUY | ₹93,781.58 Cr | 152.65% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹45,588.15 Cr | 76.81% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹1,00,765.01 Cr | 77.75% | 0.65 | ₹917 Cr | ₹19,059 Cr |
Company Information
Narayana Hrudayalaya Ltd offers a wide range of healthcare services, including cardiology, oncology, orthopedics, neurology, nephrology, and gastroenterology. It also provides a range of primary care services such as preventive health check-ups, nutrition counselling, and health education. The company's top products include cardiac care, oncology, orthopedic care, and neurosciences. Its popular brands include Narayana Health, Narayana Multispecialty Hospital, and Narayana Institute of Cardiac Sciences.
Share Price: ₹1273.85 per share as on 18 Sep, 2024 04:01 PM
Market Capitalisation: ₹26,236.86Cr as of today
Revenue: ₹1,340.95Cr as on June 2024 (Q2 24)
Net Profit: ₹201.49Cr as on June 2024 (Q2 24)
Listing date: 06 Jan, 2016
Chairperson Name: DEVI PRASAD SHETTY
| Organisation | Narayana Hrudayalaya Ltd |
| Headquarters | Bangalore |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Narayana Hrudayalaya Ltd
HSBC Downgrades Narayana Hrudayalaya, Shares Decline - 13 Sep, 2024
HSBC initiated coverage on Narayana Hrudayalaya with a 'Reduce' rating and a target of Rs 1,000, predicting a 27% downside due to anticipated margin pressures. Following this news, shares dropped nearly 5%.
Narayana Hrudayalaya Reports Strong Q1FY25 Growth - 12 Sep, 2024
Narayana Hrudayalaya Limited's Q1FY25 results show an 8.72% YoY revenue growth to Rs. 1,341 Crores, with profits rising from Rs. 184 Crores to Rs. 202 Crores. The company maintains a bed capacity of 6,254.
Narayana Hrudayalaya Stock Shows Bullish Momentum - 09 Sep, 2024
Narayana Hrudayalaya stock has experienced a consolidation breakout, supported by strong volume and bullish indicators. Analysts recommend accumulating shares in the Rs 1,350-1,340 range, with a target of Rs 1,410 and Rs 1,450 in the short term.
Narayana Hrudayalaya Reports Strong Growth and Future Plans - 05 Sep, 2024
Narayana Hrudayalaya shows robust growth with an 8.7% revenue increase to Rs1,341 crore in Q1FY24-25. The company plans Rs3,000 crore in capex over the next few years, aiming for sales of Rs5,700 crore in FY24-25, potentially leading to a net profit of Rs850 crore. With a P/E ratio of 40, the market cap could rise significantly, indicating a positive outlook.
Narayana Hrudayalaya Maintains Buy Rating with Revised Target - 03 Sep, 2024
Narayana Hrudayalaya's management outlined aggressive expansion plans, aiming to add 1,500 beds by FY28/29. Despite a slight reduction in EBITDA estimates, a BUY rating is maintained with a revised target price of Rs 1,420/share.
Insights on Narayana Hrudayalaya Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 188.02 Cr → 201.38 Cr (in ₹), with an average increase of 3.4% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.22K Cr → 1.36K Cr (in ₹), with an average increase of 5.4% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 15.11% to 17.29% in Jun 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 158.5% return, outperforming this stock by 14.8%
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 85.6% return, outperforming this stock by 68.8%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 63.85% of holdings in Jun 2024 quarter
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 7.18% to 5.99% in Jun 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, NH stock has moved down by -3.3%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 10.91% to 10.01% in Jun 2024 quarter
Company Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 63.85% | 0.00 | |
| Foreign Institutions | 10.01% | ||
| Mutual Funds | 5.99% | ||
| Retail Investors | 17.29% | 14.42 | |
| Others | 2.86% |
Key Indicators
Narayana Hrudayalaya Ltd Valuation
Narayana Hrudayalaya Ltd in the last 5 years
Lowest (-711.13x)
June 2, 2021
Today (32.31x)
September 17, 2024
Industry (96.97x)
September 17, 2024
Highest (152.38x)
November 14, 2018
Earnings and Dividends
Narayana Hrudayalaya Ltd Earnings Results
Narayana Hrudayalaya Ltd’s net profit jumped 9.48% since last year same period to ₹201.38Cr in the Q1 2024-2025. On a quarterly growth basis, Narayana Hrudayalaya Ltd has generated 5.59% jump in its net profits since last 3-months.
Read More about Earnings ResultsNarayana Hrudayalaya Ltd Dividends May,2024
In the quarter ending March 2024, Narayana Hrudayalaya Ltd has declared dividend of ₹4 - translating a dividend yield of 0.31%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Narayana Hrudayalaya Ltd is currently in a Bearish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Narayana Hrudayalaya Ltd shares.
Narayana Hrudayalaya Ltd (NH) share price today is ₹1273.85
Narayana Hrudayalaya Ltd is listed on NSE
Narayana Hrudayalaya Ltd is listed on BSE
- Today’s highest price of Narayana Hrudayalaya Ltd is ₹1294.35.
- Today’s lowest price of Narayana Hrudayalaya Ltd is ₹1263.5.
PE Ratio of Narayana Hrudayalaya Ltd is 32.31
PE ratio = Narayana Hrudayalaya Ltd Market price per share / Narayana Hrudayalaya Ltd Earnings per share
Today’s traded volume of Narayana Hrudayalaya Ltd(NH) is 1.86L.
Today’s market capitalisation of Narayana Hrudayalaya Ltd(NH) is ₹26236.86Cr.
| Narayana Hrudayalaya Ltd(NH | Price |
|---|---|
52 Week High | ₹1444.9 |
52 Week Low | ₹979.95 |
Narayana Hrudayalaya Ltd(NH) share price is ₹1273.85. It is down -11.84% from its 52 Week High price of ₹1444.9
Narayana Hrudayalaya Ltd(NH) share price is ₹1273.85. It is up 29.99% from its 52 Week Low price of ₹979.95
| Narayana Hrudayalaya Ltd(NH | Returns |
|---|---|
1 Day Returns | -10% |
1 Month Returns | 8.12% |
3 Month Returns | 3.74% |
1 Year Returns | 16.79% |